Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway

por Pan, Yong-hong, Jiao, Lin, Lin, Cai-yu, Lu, Cong-hua, Li, Li, Chen, Heng-yi, Wang, Yu-bo, He, Yong
Publicado 2018